Critical Respiratory Diseases in Ex-preterm Infants in PICU
The Epidemiology of Critical Respiratory Diseases in Ex-preterm Infants Admitted to the Pediatric Intensive Care in Vietnam
1 other identifier
observational
202
1 country
1
Brief Summary
Premature birth is the leading cause of death in children younger than 5 years old worldwide, especially in low- and middle-income countries. Premature infants who survive are at greater risk of a range of short-term and long-term health consequences. Common long-term health morbidities among children who are born prematurely include cerebral palsy, infections (particularly respiratory infections), bronchopulmonary dysplasia, feeding difficulties, hypoxic-ischemic encephalopathy, visual and hearing problems. Re-hospitalization occurs frequently during first few years of life among ex-premature infants with respiratory illness. This leads to increased financial burden for health care system and families. The impact of prematurity on the health care system, especially on pediatric intensive care units (PICUs) has mainly been evaluated in high income countries. Little is known about long term health outcomes of ex-premature infants and their impact on the cost to health care system in low- and middle-income countries. This pilot, single institution, observational study aims to determine the prevalence, course of the diseases, and outcomes of ex-premature infants with respiratory illnesses who are admitted to a PICU of a tertiary children's hospital in Vietnam. Investigators will determine the epidemiology of respiratory illness, and the resource utilization for these children in the PICU. To achieve these aims, the investigators will prospectively screen and recruit all children aged less than 2 years old admitted to the PICU with respiratory illness/failure and collect pertinent clinical data. The study participants will be follow-up until PICU discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2019
CompletedStudy Start
First participant enrolled
November 1, 2019
CompletedFirst Posted
Study publicly available on registry
February 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2021
CompletedMay 2, 2022
April 1, 2022
1.6 years
September 21, 2019
April 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Percentage of ex-premature infants aged < 2 years admitted to Pediatric Intensive Care Unit (PICU)
The percentage of ex-premature patients to the total number of patients aged ≤ 2 years age admitted to PICU over a defined period
Through study completion, an average of 1 year
Percentage of ex- premature infants aged < 2 years admitted to PICU with critical respiratory diseases.
The percentage of ex-premature patients to the total number of patients aged ≤ 2 years age with respiratory illness admitted to PICU over a defined period
Through study completion, an average of 1 year
Secondary Outcomes (7)
Percentage of identified pathogens of critical respiratory diseases among study participants
Up to 60 days
Number of participants with all-cause mortality
Up to 60 days
Time from start to end of mechanical ventilation
Up to 60 days
Time from pediatric intensive care unit (PICU) admission to PICU discharge
Up to 60 days
Percentage of participants receiving mechanical ventilation support
Up to 60 days
- +2 more secondary outcomes
Eligibility Criteria
All patients aged ≤ 2 year olds with respiratory diseases
You may qualify if:
- All patients aged ≤ 2 year olds with respiratory diseases admitted to pediatric intensive care unit of Vietnam National Children's Hospital
You may not qualify if:
- Nil
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Children's Hospital, Vietnamlead
- KK Women's and Children's Hospitalcollaborator
- Duke-NUS Graduate Medical Schoolcollaborator
Study Sites (1)
Vietnam National Children's Hospital
Hanoi, Vietnam
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Phuc H Phan, MD
Vietnam National Children's Hospital
- PRINCIPAL INVESTIGATOR
Jan Hau Lee, MD
Duke-NUS Medical, Singapore
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Director of Pediatric Intensive Care Unit
Study Record Dates
First Submitted
September 21, 2019
First Posted
February 26, 2020
Study Start
November 1, 2019
Primary Completion
May 30, 2021
Study Completion
May 30, 2021
Last Updated
May 2, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share